We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$166M
AUM Growth
+$4.72M
Cap. Flow
+$4.91M
Cap. Flow %
2.96%
Top 10 Hldgs %
72.14%
Holding
622
New
62
Increased
177
Reduced
49
Closed
35

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$1.4M
2
NEO icon
NeoGenomics
NEO
+$1.27M
3
CNTA
Centessa Pharmaceuticals
CNTA
+$882K
4
ATEC icon
Alphatec Holdings
ATEC
+$582K
5
TRV icon
Travelers Companies
TRV
+$549K

Top Sells

Rank Stock Value
1
MODN
MODEL N, INC.
MODN
+$1.03M
2
TELA icon
TELA Bio
TELA
+$980K
3
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$535K
4
IWM icon
iShares Russell 2000 ETF
IWM
+$319K
5
IUSV icon
iShares Core S&P US Value ETF
IUSV
+$82.3K

Sector Composition

Rank Sector Weight
1 Healthcare 10.57%
2 Financials 4.94%
3 Technology 3.85%
4 Industrials 1.42%
5 Consumer Staples 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONEV icon
301
State Street SPDR Russell 1000 Low Volatility Focus ETF
ONEV
$304M
$8.87K 0.01%
75
– –
ZS icon
302
Zscaler
ZS
$23.8B
$8.84K 0.01%
46
+4
+10% +$712
SNY icon
303
Sanofi
SNY
$105B
$8.83K 0.01%
182
– –
BIDU icon
304
Baidu
BIDU
$35.8B
$8.82K 0.01%
102
– –
NRG icon
305
NRG Energy
NRG
$28.8B
$8.69K 0.01%
112
+1
+0.9% +$77
PLTR icon
306
Palantir
PLTR
$315B
$8.69K 0.01%
343
+193
+129% +$4.35K
QCOM icon
307
Qualcomm
QCOM
$179B
$8.68K 0.01%
44
+1
+2% +$189
CMS icon
308
CMS Energy
CMS
$22.9B
$8.57K 0.01%
144
+17
+13% +$1.03K
INTU icon
309
Intuit
INTU
$83.1B
$8.54K 0.01%
13
– –
TTD icon
310
Trade Desk
TTD
$8.41B
$8.5K 0.01%
87
+17
+24% +$1.53K
DVAX
311
DELISTED
Dynavax Technologies
DVAX
$8.42K 0.01%
750
– –
NOV icon
312
NOV
NOV
$7.35B
$8.4K 0.01%
+442
New +$8.28K
FBTC icon
313
Fidelity Wise Origin Bitcoin Fund
FBTC
$12.1B
$8.39K 0.01%
160
-35
-18% -$2.01K
RHI icon
314
Robert Half
RHI
$4.07B
$8.38K 0.01%
131
+34
+35% +$2.33K
TJX icon
315
TJX Companies
TJX
$173B
$8.37K 0.01%
76
– –
EPC icon
316
Edgewell Personal Care
EPC
$1.28B
$8.36K 0.01%
208
– –
TTC icon
317
Toro Company
TTC
$9.01B
$8.32K 0.01%
89
+37
+71% +$3.26K
IAT icon
318
iShares US Regional Banks ETF
IAT
$673M
$8.29K 0.01%
+200
New +$8.27K
ASML icon
319
ASML
ASML
$636B
$8.18K ﹤0.01%
8
-1
-11% -$961
AR icon
320
Antero Resources
AR
$10.5B
$8.16K ﹤0.01%
250
– –
GILD icon
321
Gilead Sciences
GILD
$162B
$8.04K ﹤0.01%
117
+1
+0.9% +$67
HCAT icon
322
Health Catalyst
HCAT
$159M
$7.99K ﹤0.01%
1,250
– –
ON icon
323
ON Semiconductor
ON
$34.7B
$7.95K ﹤0.01%
116
+7
+6% +$491
CLX icon
324
Clorox
CLX
$11.8B
$7.92K ﹤0.01%
58
+9
+18% +$1.25K
PIPR icon
325
Piper Sandler
PIPR
$5.15B
$7.85K ﹤0.01%
+136
New +$6.97K
11 12
13
14 15

Similar funds

PPA
Pilgrim Partners Asia Singapore $246M AUM
IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return

HighMark Wealth Management's Q2 2024 Portfolio in Review

As of Q2 2024, HighMark Wealth Management held 622 positions worth $166M, up 2.9% from $161M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

HighMark Wealth Management's Q2 2024 filing shows 62 new, 177 increased, 49 reduced and 35 closed positions. Its largest new stake was Centessa Pharmaceuticals: 93,000 shares worth $840K. The largest sale was MODEL N, INC., an estimated $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.1% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q2 2024 buy was Centessa Pharmaceuticals: 93,000 shares worth $840K.
  • HighMark Wealth Management added most to AtriCure in Q2 2024, an estimated $1.4M increase.
  • HighMark Wealth Management's biggest Q2 2024 reduction was TELA Bio, cutting an estimated $980K.
  • HighMark Wealth Management fully exited MODEL N, INC. in Q2 2024, selling an estimated $1.03M.
  • HighMark Wealth Management's ten largest holdings make up 72% of its $166M portfolio in Q2 2024.
  • HighMark Wealth Management opened 62 new positions and closed 35 in Q2 2024.
  • HighMark Wealth Management's portfolio value rose 2.9% quarter-over-quarter to $166M.

Based on HighMark Wealth Management's 13F filing for Q2 2024, filed 29 Jul 2024.